Seek and Hide Phosphatidylserine: A New Approach to Prevent Hepatic Ischemia/Reperfusion Injury

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 713-716

  Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; CASPASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DIANNEXIN; EBSELEN; GABEXATE MESILATE; GALLIC ACID PROPYL ESTER; GREEN TEA EXTRACT; HOMODIMER; LIPOCORTIN 5; OZAGREL; PADGEM PROTEIN; PENTOXIFYLLINE; PHOSPHATIDYLSERINE; PROSTAGLANDIN DERIVATIVE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SUPEROXIDE DISMUTASE; TACROLIMUS; TAK 044; TRIMETAZIDINE; TROLOX C; UNCLASSIFIED DRUG;

CYTOKINE PRODUCTION; EDITORIAL; LIVER CIRCULATION; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 34547548986     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.06.030     Document Type: Editorial

References (31)

1. Serracino-Inglott F., Habib N.A., and Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160-166
2. Selzner M., and Clavien P.-A. Fatty liver in liver transplantation and surgery. Semin Liver Dis 21 (2001) 105-113
3. Broelsch C., Testa G., Alexandrou A., et al. Living related liver transplantation: medial and social aspect of a controversial therapy. Gut 5 (2002) 143-145
4. Jaeschke H., and Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125 (2003) 1246-1257
5. Carini R., Autelli R., Bellomo G., et al. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 248 (1999) 280-293
6. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-S44
7. Jaeschke H. Mechanisms of liver injury II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol 290 (2006) G1083-G1088
8. Bilzer M., and Gerbes A. Preservation injury of the liver. Mechanisms and novel therapeutic strategies. J Hepatol 32 (2000) 508-515
9. Selzner N., Rudiger H., Graf R., et al. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
10. Casillas-Ramirez A., Mosbah I.B., Ramalho F., et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79 (2006) 1881-1894
11. Carini R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003) 1480-1491
12. Carini R., Alchera E., De Cesaris M.G., et al. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia. J Hepatol 45 (2006) 236-245
13. Iniguez M., Berasain C., Martinez-Anso E., et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med 203 (2006) 2809-2815
14. Banga N.R., Homer-Vanniasinkam, Graham A., et al. Ischemic preconditioning in transplantation and major resection of the liver. Br J Surg 92 (2005) 528-538
15. Serafin A., Roselo-Catafau J., Prats N., et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 161 (2002) 587-601
16. Gou R.F., Roselo-Catafau J., Casillas-Ramirez A., et al. How ischemic preconditioning protects small liver grafts. J Pathol 208 (2006) 62-73
17. Glantzounis G.K., Salacinski H.J., Yang W., et al. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 11 (2005) 1031-1047
18. Glantazounis GK, Mikhailidis DP, Seifalian AM, Davidson BR (eds). Curr Pharm Des 2007;12:2867-2992.
19. Teoh N.C., Ito Y., Field J., et al. Diannexin, a novel Annexin V homodimer, provides prolonged protection against hepatic ischemia reperfusion injury in mice. Gastroenterology 133 (2007) 632-646
20. Kuypers F.A., Larkin S.K., Emeis J.J., et al. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 97 (2007) 478-486
21. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol Rev 82 (2002) 331-371
22. Boersma H.H., Kietselaer B.L., Stolk L.M., et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46 (2005) 2035-2050
23. Reutelingsperger C.P. Annexins: key regulators of haemostasis, thrombosis, and apoptosis. Thromb Haemost 86 (2001) 413-419
24. Hammill A.K., Uhr J.W., and Scheuermann R.H. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic cell death. Exp Cell Res 251 (1999) 16-21
25. Natori S., Selzner M., Valentino K.L., et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 68 (1999) 89-96
26. Gujral J., Bucci T., Farhood A., et al. Mechanisms of cell death during warm hepatic ischemia-reperfusion in rat: apoptosis or necrosis. Hepatology 33 (2001) 397-405
27. Qin X., and Gao B. The complement system in liver diseases. Cell Mol Immunol 3 (2006) 333-340
28. Arumugam T.V., Shiels I.A., Woodruff T.M., et al. The role of the complement system in ischemia-reperfusion injury. Shock 21 (2004) 401-409
29. Mold C., and Morris C.A. Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation. Immunol 102 (2001) 359-364
30. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Throm Heamost 1 (2003) 1655-1662
31. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Artheroscler Thromb Vasc Biol 26 (2006) 2594-2604